Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.42
11.34
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MRVI stock under the Base Case scenario is 3.79 USD. Compared to the current market price of 5.22 USD, Maravai LifeSciences Holdings Inc is Overvalued by 27%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Maravai LifeSciences Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MRVI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Maravai LifeSciences Holdings Inc
Balance Sheet Decomposition
Maravai LifeSciences Holdings Inc
Current Assets | 679.1m |
Cash & Short-Term Investments | 578.2m |
Receivables | 28.9m |
Other Current Assets | 72.1m |
Non-Current Assets | 599.1m |
PP&E | 164.6m |
Intangibles | 373.6m |
Other Non-Current Assets | 60.9m |
Current Liabilities | 63.2m |
Accounts Payable | 9.5m |
Accrued Liabilities | 36.4m |
Other Current Liabilities | 17.4m |
Non-Current Liabilities | 869.8m |
Long-Term Debt | 547.6m |
Other Non-Current Liabilities | 322.2m |
Earnings Waterfall
Maravai LifeSciences Holdings Inc
Revenue
|
276.9m
USD
|
Cost of Revenue
|
-148.5m
USD
|
Gross Profit
|
128.4m
USD
|
Operating Expenses
|
-173.5m
USD
|
Operating Income
|
-45.2m
USD
|
Other Expenses
|
-179.5m
USD
|
Net Income
|
-224.7m
USD
|
Free Cash Flow Analysis
Maravai LifeSciences Holdings Inc
USD | |
Free Cash Flow | USD |
MRVI Profitability Score
Profitability Due Diligence
Maravai LifeSciences Holdings Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Maravai LifeSciences Holdings Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
MRVI Solvency Score
Solvency Due Diligence
Maravai LifeSciences Holdings Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Maravai LifeSciences Holdings Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc
According to Wall Street analysts, the average 1-year price target for MRVI is 9.92 USD with a low forecast of 7.07 USD and a high forecast of 13.86 USD.
Dividends
Current shareholder yield for MRVI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
MRVI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 470 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The firm's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The company also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The firm provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.
Contact
IPO
Employees
Officers
The intrinsic value of one MRVI stock under the Base Case scenario is 3.79 USD.
Compared to the current market price of 5.22 USD, Maravai LifeSciences Holdings Inc is Overvalued by 27%.